Drugmaker Eli Lilly and Co. plans to lay off about 1,000 domestic sales representatives, or 30% of its U.S. sales force, as it faces new generic competition for its top drugs, a person familiar with the matter said on Friday.
Lilly to cut 1,000 U.S. sales jobs: source
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.